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The patient was promptly consulted by the Pul‑
monary Embolism Response Team (PERT) com‑
posed of a cardiac surgeon and invasive cardiol‑
ogist, who recommended USAT, and the patient 
was transferred to a catheterization laborato‑
ry. Right heart catheterization revealed an ele‑
vated systolic pulmonary artery pressure (sPAP) 
of 63 mm Hg and impaired cardiac index (CI) 
of 1.63 l/min/m2. Two USAT catheters were po‑
sitioned into both pulmonary arteries via the 
femoral vein access under fluoroscopy guidance, 
and the infusion of ultrasound ‑assisted alteplase 
1 mg/h/catheter was started (Figure 1D). USAT was 
continued at the intensive care unit for 5 hours 
with the total alteplase dose of 10 mg. Symp‑
toms, clinical status, and biomarker levels grad‑
ually improved during therapy (see the legend 
to Figure 1). The sPAP decreased to 39 mm Hg and 
CI increased to 2 l/min/m2 on USAT completion. 
CTPA revealed reduction of the thrombus burden 
and a decrease of the RV/LV ratio to 0.86 (Figure 1e 
and 1F). No adverse events occurred. On the sec‑
ond postprocedural day, the patient was trans‑
ferred back to the orthopedic department in sta‑
ble clinical condition.
This is the first report in Poland of the USAT 
use in a patient with acute intermediate ‑high risk 
PE, following the decision by the PERT. The re‑
port showed that this method may offer an ef‑
fective therapeutic option for patients with life‑
‑threatening acute PE, minimizing the risk of 
bleeding complications. A prospective EKOS ‑PL 
study is underway.
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Patients at high and intermediate ‑high risk of ear‑
ly death from acute pulmonary embolism (PE) are 
candidates for reperfusion therapy with the use 
of full ‑dose, systemic thrombolysis.1 Howev‑
er, such therapy carries a significant risk of life‑
‑threatening bleeding complications and is con‑
traindicated in a vast number of patients.
Percutaneous therapies are increasingly com‑
mon in the treatment of chronic and acute pulmo‑
nary circulation diseases.2,3 A novel ultrasound‑
‑assisted, catheter ‑directed, low ‑dose thrombol‑
ysis (USAT) has been indicated to facilitate pul‑
monary artery reperfusion, with a significantly 
reduced bleeding risk.4,5 Acoustic pulses, deliv‑
ered into a thrombus by specialized intravascular 
catheters, unwind fibrin strands and drive the lyt‑
ic drug deeper into the clot, allowing for lower‑
‑dose and high reperfusion efficacy.4,5
We have recently implemented USAT to treat 
a patient with life ‑threatening acute PE, who 
carried an increased risk of bleeding complica‑
tions. A 67 ‑year ‑old man with multiple pelvic 
and femoral fractures developed an acute PE 
while awaiting reconstructive operation. De‑
spite hemodynamic instability, systemic throm‑
bolysis was contraindicated due to high bleed‑
ing risk. As no clinical improvement on intra‑
venous anticoagulation was achieved, the pa‑
tient was transferred to our hospital. On ad‑
mission, he complained of dyspnea; his heart 
rate was 115 bpm; blood pressure, 95/55 mmHg; 
and oxygen saturation, 89%. The simplified pul‑
monary embolism severity index score was 3. 
Computed tomography pulmonary angiogra‑
phy (CTPA) showed centrally located bilateral 
thrombi, and enlargement of the right ventri‑
cle with the right ventricular ‑to ‑left ventricular 
(RV/LV) ratio of 1.2 (Figure 1a–1c). Blood levels of 
N ‑terminal ‑pro ‑B‑type natriuretic peptide and 
troponin T were elevated.
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Figure 1 a, B, c – computed tomography pulmonary angiography (CTPA) showing thrombus (arrow) in the proximal 
right interlobar pulmonary artery (PA) (a) and in the middle part of the left interlobar PA (dashed arrow) (B), causing dilation 
of the right ventricle with the right ventricular -to -left ventricular (RV/LV) ratio of 1.2 (c); D – fluoroscopy showing two 
EkoSonic® MACH4 catheters of the EKOS™ system (Ekos Corp., Bothel, Washington, United States) for ultrasound-
-assisted, catheter -directed, low -dose thrombolysis (USAT), located in the right and left PAs beyond the thrombi;  
e, F – CTPA performed after 5 -hour USAT with the total alteplase dose of 10 mg, showing thrombus resolution in the left 
PA (dashed arrow) and a reduction of thrombus burden in the right PA (arrow) (e), leading to a decrease in the RV/LV ratio 
to 0.86 (F). Moreover, the USAT led to a gradual relief of dyspnea, an increase of systolic blood pressure to 110 mm Hg and 
oxygen saturation to 95%, a decrease of heart rate to 90 bpm, and a decrease of the N -terminal -pro -B-type natriuretic 
peptide level from 4784 pg/ml to 3321 pg/ml and of the troponin T level from 0.115 ng/ml to 0.098 ng/ml.
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